Skip to main
OSCR
OSCR logo

Oscar Health (OSCR) Stock Forecast & Price Target

Oscar Health (OSCR) Analyst Ratings

Based on 7 analyst ratings
Sell
Strong Buy 0%
Buy 0%
Hold 29%
Sell 57%
Strong Sell 14%

Bulls say

Oscar Health Inc. reported a significant year-over-year revenue increase of 29.0% in 2Q25, reaching $2.86 billion, driven by strong retention rates and new member additions. The company's medical loss ratio (MLR) of 91.1% exceeded consensus estimates, indicating improved cost management and enhanced operational efficiency despite market-wide challenges. Additionally, management anticipates increased utilization in 4Q25, which may positively impact future growth prospects.

Bears say

Oscar Health Inc. reported a 2Q25 operating income of ($230.5 million) and an adjusted EBITDA of ($199.4 million), both of which fell short of consensus expectations, indicating ongoing financial struggles. Additionally, the company's SG&A ratio improved to 18.7%, a decline of 90 basis points year-over-year, yet this is unlikely to sufficiently offset the significant operating losses. Furthermore, management anticipates a modest decline in individual membership by year-end, raising concerns about future revenue growth and overall market positioning.

Oscar Health (OSCR) has been analyzed by 7 analysts, with a consensus rating of Sell. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 29% suggest Holding, 57% advise Selling, and 14% predict a Strong Sell.

This aggregate rating is based on analysts' research of Oscar Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Oscar Health (OSCR) Forecast

Analysts have given Oscar Health (OSCR) a Sell based on their latest research and market trends.

According to 7 analysts, Oscar Health (OSCR) has a Sell consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Oscar Health (OSCR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.